CJC-1295 (without DAC) is a GHRH analogue that stimulates growth hormone release, while Ipamorelin is a selective GH secretagogue that amplifies that release with minimal effect on cortisol or prolactin
Furthermore, the patients should be informed about the possible risks and receive regular dermatological and ophthalmological controls
Research using GHRP-2 has characterised GHS-R1a intracellular signalling dynamics including PLC activation, DAG/PKC cascades, and calcium-dependent GH vesicle exocytosis at stimulus intensities not achievable with GHRP-6 or Ipamorelin at equivalent concentrations
The proposed purpose is to protect it during digestion and facilitate delivery across biological membranes
J Gen Intern Med 23:210213 Karakoc E, Erdem S, Sokmensuer C, Kansu T (2006) Encephalopathy due to carnitine deficiency in an adult patient with gluten enteropathy
BPC-157 and TB-500 on the other hand still lack randomized controlled trials in humans